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Background: The prevalence of obesity is increasing exponentially world over. Leptin resistance/hyperleptinemia is
attributed to its cause in majority of the obese humans where mutation in genetic component or ob gene has not
been found operative. The generation of oxidative stress was suggested as its cause. In our previous study, we have
reported that the inclusion of antioxidant enriched modified poultry egg (ME) in diet reversed the ionic imbalance
and ameliorated the oxidative stress caused by excessive Zn in diet. In the present study, the efficacy of ME verses
conventional egg (CE) was tested on Zn-induced leptin resistance in rat model to ascertain if the supplementation
of antioxidants in the form of egg can reverse Zn-induced leptin resistance to leptin sensitive state.
Methods: Hyperleptinemia was induced in rats by feeding them Zn-supplemented hyperleptinemic diets-I and II
(Zn-HL-Diet) for 2 months. Thereafter, half of them were fed either on CE or ME mixed Zn-HL-diets I and II for
another two months. The data was analyzed applying one way Anova and Tukey’s HSD post hoc test.
Results: The results revealed that food intake, gain in body weight, height and number/unit surface area of
intestinal microvillus and serum leptin, glucose, insulin and cortisol were higher in CE and Zn-HL-Diet treated
groups; serum Zn, Cu, Mg were higher and Cu and Mg in tissues were lower in them than the control group. In ME
treated groups, these parameters were lower and were close to the control group. These changes resulted from the
restoration of ionic balance of Zn, Cu and Mg in the blood serum and tissues including liver and hair in ME treated
rats.
Conclusion: The data suggest that Zn-induced leptin resistance can be attenuated through restoring the ionic
balance of Zn, Cu and Mg through inclusion of antioxidants in diet such as these modified eggs. But further clinical
studies are required before they are put to use for human consumption.
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Obesity is one of the most serious physiological disorders as
it increases the risks of hypertension, non-insulin dependent
diabetes mellitus, coronary artery disease, stroke, renal fail-
ure, gall bladder stones and certain types of cancer. Previous
study on the molecular defect underlying the development
of obesity in genetically recessive ob/ob mouse led to the
discovery of leptin, a cytokine-like factor, produced predom-
inantly in white adipose tissue [1]. Leptin administration in* Correspondence: sktaneja@gmail.com
Department of Zoology, Panjab University, Chandigarh 160014, India
© 2012 Taneja et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orob/ob obese mice causes an increase in energy expenditure
and decrease in appetite [2-5] by depressing hypothalamic
levels of orexigenic neurotransmitters [5,6]. It led to the as-
sumption that human obesity may also be a leptin-deficient
state that could be treated with exogenous leptin administra-
tion. However several population studies have failed to dem-
onstrate such mutations [7-9] (except in a small fraction of
population), instead majority of them have increased leptin
levels, indicating that obesity is a leptin resistant states in
most obese [9].
The leptin gene expression is mainly influenced by food
intake, greatly reduced after fasting, increased by re-feeding
both in rodents and humans correlated with changes inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reported that excessive Zn in diet induces obesity, hyperin-
sulinemia and hypercortisolemia as a consequence of ionic
imbalance of Zn, Cu and Mg [12] resulting in oxidative
stress [13] and leptin resistance in Wistar rats [14].
The implication of these reports has a direct relationship
of excessive Zn in diet to the obesity and obesity related
diseases, the incidence of which are increasing consistently
during the past two decades due to its indiscriminate use
in agriculture and animal husbandry practices and its in-
clusion in baby foods that has led to its increased con-
sumption [15,16]. This warrants some mechanism which
may not allow creating the ionic imbalance due to exces-
sive consumption of Zn in diet and preventing the onset of
oxidative stress, leptin resistance and protect the consu-
mers from obesity and obesity related diseases. Aiming
this, the poultry egg is modified with lower level of choles-
terol, enriched with Cu, Mg, vitamin E and linolenic acid
(Indian Patent No. 253740). The severity of physiological
disorders due to oxidative stress caused by excessive Zn
decreased significantly on feeding these modified poultry
egg (ME) mixed diets by restoring the minerals levels in
blood serum and tissues as reported in the previous study
[17]. Therefore, the present work was undertaken to study
the effect of ME verses conventional egg (CE) on Zn
induced hyperleptinemia [14] and results are reported in
this paper.
Methods
For the present investigations, 42 male Wistar rats were
procured from the Central Animal House (Panjab Uni-
versity, Chandigarh) and maintained in plastic cages with
stainless steel top grills at room temperature 25-28°C
with 12:12 hours L:D cycle and 70-80% relative humid-
ity. They were used in this study after taking approval of
the protocol from Institutional Ethics Committee.
$Semi-synthetic basal diet was employed with increasing
Zn concentration to induce hyperleptinemia [14].
$The semi-synthetic basal diet contained [12] (g/100 of
diet) : Casein, 30; Agar, 2.0; Corn oil, 5; Cellulose, 8; Sucrose,
51; Vitamin mixture 0.5 [Vitamin mixture (mg/Kg): Asc-
orbic acid, 500; Biotin, 4; Calcium pentothenate, 320; Cho-
line chloride, 2500; Folic acid,10; Inositol,1000; Nicotinic
acid, 300; Pyridoxine HCl, 180; Riboflavin, 120; Thiamin
HCl 200; α-tocopherol acetate (E), 60; Cyanocobalamin,0.40;
Retinol, 0.30; Ergacalciferol, 0.0031] and mineral mixture,3.5
[Mineral mixture (gm/Kg) : CaH2P04, 25.30; C0Cl3, 0.04;
CuCl2, 0.10; FeS04.7 H20, 0.60; MnS04.H20, 0.30; MgS04.
H20, 4.05; KCl, 3.43; KI, 0.004; Na2C03, 1.15; NaF,0.008;
ZnS04.7 H20, 0.088g].
Modification of basal diet
The basal diet was divided into 3 parts and modified as (i)
Basal diet containing 20 mg Zn/Kg diet for control group-I, (ii) Zn- induced-hyperleptinemic-diet-1 (Zn-HL-diet-I)
containing 40 mg Zn/kg diet and (iii) Zn induced
hyperleptinemic-diet II (Zn-HL-diet-II) containing 80 mg
Zn/Kg diet by accordingly increasing ZnS04.7 H20 in the
basal diet.
For the preparation of these diets, the ingredients were
weighed. The water soluble vitamins were thoroughly
grounded and mixed along with sucrose, while the fat
soluble vitamins were dissolved in corn oil. Agar, used as
a binding agent was dissolved in 100 ml of double dis-
tilled deionised water with constant stirring on water
bath maintained at 60°C. On its cooling to 40°C, the
contents of each diet were thoroughly mixed in separate
containers. The dough so formed was put in Petri dishes
and solidified in refrigerator for 3 hours to harden the
wet fresh diets. The solidified diets were then cut into
small pieces of 2 cm×2 cm× 2 cm size and stored in the
containers at <−4°C.
In order to study the effect of ME, test diets-A and B
were prepared after adding four liquid ME (50 g per
egg/kg of diet) in Zn-HL-diet-I (Diet-A) and Zn-HL-
diet-II (Diet-B). Similarly, the test diets C and D were
prepared after adding 4 liquid CE (50 g/kg diet) in
Zn-HL-diet I (Diet-C) and Zn-HL-diet II (Diet-D)
respectively.
Experimental design and feeding of rats
The male Wistar rats (n = 42) were divided into three
groups: control group-I (control, n = 6), group-II (n =
18) and group-III (n = 18) and were fed on basal diet,
Zn-HL-diet-I and Zn-HL-diet-II respectively for 60 days.
On day 60, the rats of Group-II were subdivided equally
into 3 subgroups as subgroup-II, subgroup-IICE, sub-
group-IIME, and similarly group-III into subgroup-III,
subgroup-IIICE and subgroup-IIIME including 6 rats in
each subgroup. The control group-I, subgroup-II (group-II)
and subgroup-III (group-III) were continued to feed on
their respective basal diets, Zn–HL-diet-I and II for another
60 days completing 120 days. The rats of subgroups-IIME
and IIIME were shifted to respective ME-mixed Zn-HL-
diet-I (diets-A) and II (diet-B), and the rats in subgroups-
IICE and IIICE on CE-mixed Zn-HL-diet-I (diet-C) and II
(diet-D) respectively for another 60 days thus completing
120 days of the experiment. The data of food intake and
body weight were recorded on monthly basis during dietary
treatment. They were sacrificed using diethyl ether as
anesthesia at the end of the experiment.
Hormones and mineral analysis
The blood was collected into metal free centrifuge tube by
puncturing the heart of rats in each group and subgroups
after 120 days of treatment and the blood serum was sepa-
rated and poured into separate metal free plastic vials. The
haemolysed blood samples were excluded in the present
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available diagnostic kit (Reckon Diagnostics PVT, LTD,
Baroda, India). Hormonal analysis included insulin [18,19]
by a solid phase two site enzyme immunoassay (DRG Diag-
nostics, USA), cortisol [20,21] by enzyme immunoassay
(Microtiter strip kit supplied by Immune-Biological Labora-
tories, Hamburg) and leptin [22,23] by solid phase two site
enzyme-immunoassay (Mediagnost Aspenhaustr, D-72770
Reutlingen/Germany).
The minerals including Cu, Zn and Mg were estimated
in serum, liver and hair. The tissues were digested in nitric
acid and perchloric acid mixture (3:1 v/v) on a sand bath
until a white ash was formed. The ash so obtained was
dissolved in 6 ml of 10 mM HN03 in triplicates and fil-
tered through ash free filter paper before analysis. Miner-
als Cu, Zn and Mg were then estimated on atomic
absorption spectrophotometer (Electronic Corporation of
India Limited Hyderabad- AAS 4139) using hollow
cathode lamps (213.9, 324.8 and 285.2 nm for Zn, Cu and
Mg respectively). Standards (sigma) for these metals were
prepared by dilution in triple distilled deionized water.Pathology of intestinal epithelium
Pathology of intestinal epithelium was studied on trans-
mission electron microscope (TEM). For this study, pro-
cedure described by collect [24] was followed. Small
pieces (1 mm cubic) of small intestine (10 cm above the
caecum) were taken from freshly killed rats and washed
in 0.2 M phosphate buffer and fixed in modified kar-
novsky’s fixative (2.5% glutaraldehyde, paraformalde-
hyde, 0.2 M phosphate buffer). Post fixation was carried
out in 1% osmium tetra oxide (1% OsO4 diluted in
0.2 M phosphate buffer, pH 7.2) for 1hour at 4°C. The
intestinal pieces were dehydrated in ascending grades of
acetone (30-100%) and cleared in toluene. They were
infiltrated with spurr’s low viscosity embedding medium
by passing them through a sequence of solutions until
the dehydrating agent was completely replaced by the
final embedding mixture. The sections were cut on
RMC-MTX ultra microtome in the range of 600-800Aº
and stained with uranyl acetate followed by lead citrate
to increase the contrast.Analysis of eggs
The MEs were obtained from the hens after feeding
them on modified bird’s feed as per specification given
in Indian patent no. 253740. The CEs were obtained
from the Bee jee poultry farm, Panchkula, India. They
were analyzed for cholesterol [25,26], triglycerides [27],
total lipids [28], proteins [29], carbohydrates [30,31],
vitamin E [32,33], linolenic acid and minerals (Zn, Cu
and Mg) as described previously [17].Statistical analysis
The data were subjected to statistical analysis applying
one way ANOVA and Tukey’s post hoc test (Honestly
significant difference).
Results
Composition of ME versus CE
ME and CE typically (50 g liquid/egg) contained total lipid,
5.84±0.43 versus 7.8±0.07 (g/egg, 25.13% less); cholesterol,
110.77±3.19 versus 205.92±6.02 (mg/egg, 46.21% less); tri-
glycerides, 1.37±0.01 versus 5.5±0.06 (g/egg, 75.1% less);
protein, 6.5±0.12 versus 6.7±0.14 (g/egg, 2.98% less);
carbohydrate, 0.63±0.02 versus 0.69±0.15 (g/egg, 8.69%
less); vitamins E, 10.35±0.32 versus 3.22±0.03 (mg/egg,
68.89% higher); linolenic acid, 73.84±3.57 versus 36.0±0.01
(mg/egg, 51.24% higher); Cu, 3.02±0.04 versus 1.36±0.03
(mg/egg, 54.97% higher); Mg, 2.02±0.01 versus 0.61±0.
01(mg/egg, 69.80% higher) and Zn, 0.65±0.01 versus
2.98±0.05 (mg/egg, 78.19% less).
Food intake and body weight
The food intake and gain in body weight (g) showed sig-
nificant variation on monthly basis. They were higher in
rats of group-II (subgroup-II) and group-III (subgroup-
III). The rats in subgroup-IICE and subgroup-IIICE fed
on diets containing CE on 60th day and onwards contin-
ued to consume more food and gained more body
weight (Figure 1a, 1b). There was no significant variation
between subgroup-IICE and subgroup-IIICE but the
food intake was higher by 24.46% in subgroup-IICE and
29.49% in subgroup-IIICE than control group-I and body
weights were higher by 17.7% in subgroup-IICE and 19%
in subgroup-IIICE as evaluated on day 120 of the experi-
ment. In contrast to this, the food intake and gain in
body weight in rats of subgroup-IIME and subgroup-
IIIME fed on diets containing ME on day 60 started
gradually declining compared to subgroup-II and sub-
group-IICE, and subgroup-III and subgroup-IIICE and
approached closer to the control group-I on day 120.
The food intake was 25.54% and 27.83% (Figure 1a) and
their body weight were 20.45% and 21.15% (Figure 1b)
higher in subgroup-IICE and IIICE respectively than the
subgroup-IIME and subgroup-IIIME at the end of the
experiment.
Serum leptin, glucose, insulin and cortisol
Along with the food intake and gain in body weight, the
serum leptin (pg/ml) was found to increase in subgroup-II
and subgroup-IICE, and subgroup-III and subgroup-IIICE
(Figure 2c). Its levels were 62.90% and 63.61% higher in
subgroup-IICE and subgroup-IIICE than control group-I. Its
levels in subgroup-IIME and subgroup-IIIME did not show
any significant difference in comparison to the control
group-I suggesting that the ME did not allow the leptin level
Figure 1 Line graph showing mean month wise food intake (a) and body weights (b) of Wistar rats in groups control group-I,
subgroup-II, III, IICE, IIICE and IIME and IIIME during the 4 months of dietary treatment. [Values are mean ± SEM of n= 6]
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diets similar to subgroup-II and subgroup-III and subgroup-
IICE and subgroup-IIICE. Coinciding with the food intake,
body weight, serum leptin concentrations, the serum glu-
cose (mg/dl), insulin (pmole/L) and cortisol (ng/ml) con-
centrations increased in group-II, subgroup-IICE and
subgroup-III, subgroup-IIICE than the control group-I sug-
gesting that these rats developed hyperinsulinemia and
hypercortisolemia (Figure 2a, 2b, 2c, 2d). In contrast to this,
serum glucose, insulin and cortisol levels in subgroup-IIME
and subgroup-IIIME were closer to the control group-I. The
glucose, insulin and cortisol levels were 34.88%, 72% and
44.6% in subgroup-IIME and 22.14%, 72.5% and 42.9%
(Figure 2a, 2b, 2c, 2d) in subgroup-IIIME less than the re-
spective CE treated groups suggesting that the MEs did not
permit the rise of serum glucose, insulin and cortisol in spitea b
c d
Figure 2 Line graphs of blood profile showing serum glucose (a), insu
group-I, subgroup-II, III, IICE, IIICE and IIME and IIIME after the 4 monof the level of Zn in their diet comparable to diets fed to the
rats in subgroup-II, IICE and subgroup-III and IIICE.
Intestinal pathology
The TEM studies of intestinal segment (Additional file
1) revealed a significant increase in the absorptive sur-
face area reflected as an increase in mean height (nm)
and number/unit surface (μm) area of microvilli of its
mucosal epithelial cells in subgroup-IICE (Additional file
1b) and subgroup-IIICE (Additional file 1c) than that of
control group-I (Additional file 1a). The mean height
was found to be less by 39.9% in subgroup-IIME and
43.1% in subgroup-IIIME whereas the microvilli number
was less by 17.6% in subgroup-IIME (Additional file 1d)
and 38.3% in subgroup-IIIME (Additional file 1e) than
those of their respective CE treated groups and werelin (b), leptin (c) and cortisol (d) in male Wistar rats in control
ths of dietary treatment. [Values are mean ± SEM of n= 6].
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The increase in height and number/unit surface area in
subgroup-II and IICE, and subgroup-III and IIICE were
suggestive of the elevated capability of the intestine to
absorb the nutrients per unit time in CE treated rats
than those of ME treated rats or control group. [Electro-
micrographs of intestinal mucosal epithelial cells of
subgroup-II and subgroup-III are not shown because
the changes in their cytoarchitecture were similar to
subgroups- IICE and IIICE].
Minerals
Serum Zn, Cu and Mg (mg/dl) concentrations increased
while the tissue (liver and hair) Cu and Mg concentra-
tions (μg/g) decreased significantly in group-II, IICE and
group-III, IIICE compared to that of control group-I
(Figure 4a, 4b, 4c). The tissue concentrations of Zn were
significantly less in sub-group-IIME and sub-group-
IIIME than the CE treated rats and were close to control
group-I (Figure 4b,4c).
Discussion
The data of food intake and body weight revealed that
during the first two months of the experiment, when no
egg was added in Zn-HL-I and II diets of group-II and III,
the gain in body weight and food intake increased with in-
crease in Zn concentrations in their diets than the control
group-I. On addition of eggs in their diets after two
months of feeding on this diet, the food intake and gain in
body weight continued to display consistent rise which
were more in subgroup-IIICE than subgroup-IICE where
as their rise in subgroup-IIME and subgroup-IIIME were
less than CE treated groups but were higher than the con-
trol group-I after the completion of 3 months and
approached closer to control group-I at the end of the 4th
month of the dietary treatment. This suggested that
addition of CE in Zn-HL-diets did not affect the body
mass promoting factors. On the contrary, the ME resulted
a reduction in food intake and slower gain in body weightFigure 3 Line graphs showing mean height (a) and number/unit surfa
male Wistar rats in control group-I, subgroup-II, III, IICE, IIICE and IIMthan the CE treated rats and were comparable to control
group-I suggesting its positive role in regulation of food
intake and body weight in a manner similar to the control
group-I.
The ultra structure of intestinal segment
The increase in absorptive cell surface area both in terms
of height and number per unit surface area of intestinal
microvillus in group-II, subgroup-IICE and subgroup-III,
IIICE than IIME and IIIME (Additional file 1) implied that
the former two CE treated rats or Zn-HL-diet fed rats
have the capability of absorption of more nutrients than
the ME treated rats or control group rats as the absorp-
tion rate at intestinal level is dependent on availability of
its surface area. The greater surface area transfers more
molecules from the intestinal lumen to the epithelial cells
and to the blood stream at a faster rate than those which
have lesser surface area. This change in cyto-architecture
of the intestine in these rats possibly imposed two effects:
firstly it resulted in absorption of more nutrients from the
diet and secondly caused evacuation of stomach faster by
relieving the effect of inhibitors on the stomach motility.
These two effects were manifested in terms of higher con-
sumption of food and more gain in body weight in Zn-
HL-diet fed and CE treated rats in comparison to the ME
treated rats.
However, both food intake and body fat mass had been
reported to be regulated by leptin [3,34,35]. In the
present study, the serum leptin level was evaluated
higher in Zn-HL-diet and CE treated rats than those of
ME treated rats suggesting that the addition of ME in
Zn-HL-diets resulted in a significant reduction of circu-
lating leptin which was less than that of either Zn sup-
plement and CE treated rats. Its level in subgroup-IIME
rats was equal to control group-I while in that of sub-
group-IIIME, it was approximately 23% higher than the
control group-I.
Leptin primarily secreted by white adipocytes, targets
receptors in neurons of hypothalamic nuclei for thece area (b) of microvilli of mucosal epithelial cells of intestine in
E and IIIME after 4 months of dietary treatment.
Figure 4 Line graphs showing mean serum (a), liver (b) and hair (c) Zn, Cu and Mg concentrations in male Wistar rats in control
group-I, subgroup-II, III, IICE, IIICE and IIME and IIIME after 4 months of dietary treatment. [Values are mean ± SEM of n= 6].
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exigenic neuropeptides [36]. The administration of leptin
in recessive ob/ob mice lacking leptin gene, results in the
reduction in food intake and body fat mass in them. How-
ever in subgroups-II (group-II), IICE and subgroups-III
(group-III), IIICE, the higher level of leptin could not pro-
portionally reduce either food intake or caused reduction
in body fat mass suggesting that leptin failed to inhibit the
orexigenic neuropeptide signaling to an extent that may
be equal to control group-I. In fact, its higher levels in
groups per se caused opposite effect in them whichsuggested its resistance to orexigenic receptors. Leptin re-
sistance appears when threshold level of serum leptin
above which its increase does not translate into propor-
tional increase in cerebrospinal fluid or brain leptin level
[37]. This in turn may result in apparent leptin resistance
leading to increase in food intake and higher gain in body
weight as observed in subgroups-II and III also reported
previously [14], and subgroups-IICE and IIICE respect-
ively in the present study. In contrast, the leptin level in
subgroup-IIME and IIIME were evaluated significantly
less than those of Zn-HL-diet and CE mixed diet fed
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allow developing leptin resistance as manifested in term of
lesser food intake and lesser gain in body weight. Their
food intake and gain in body weight, and leptin levels were
almost close to the control group at the end of the
experiment.
The increased absorption rate of nutrients due to
increased surface area of absorptive mucosal epithelial
cell of intestine in subgroups-II, IICE and III, IIICE
seemed to be the possible reason for hyperleptinemia in
them since excessive absorption of nutrients stimulated
the release of excessive insulin from β cell of pancreas as
recorded in subgroups-II, IICE and III, IIICE for the
transport of extra available nutrient to the fat cells for
maintaining the homeostatic state of blood glucose lead-
ing to the growth of fat cell. This lends further support
to the reports that prolonged insulin infusion or supra-
physiological insulin level markedly increases leptin level
[38-41]. This further elucidated in this study when the
absorptive mucosal epithelial cell of the subgroups-IIME
and IIIME were taken into account. The absorptive sur-
face of intestine was equal in subgroup-IIME and con-
trol group-I so was the leptin. In subgroup-IIIME, it was
more than control group-I and so was higher leptin
level. This was further supported by data of insulin eval-
uated in this experiment where its level increased with
increase in Zn concentration in diets of subgroups-II,
IICE and III, IIICE and were significantly lower in
subgroups-IIME and IIIME comparable to control group-
I. This suggested that serum leptin level was not regulated
by Zn directly but through increase or decrease of absorp-
tion rate of nutrients which influenced the circulating in-
sulin levels.
The higher insulin production increases C-reactive pro-
tein in the blood which stimulates the corticotrophin re-
leasing hormone [42-44]. Leptin is positively correlated to
the corticotrophin releasing hormone since its level has
been seen to decrease with its reduction [45]. Higher
levels of Zn-induced glucocorticoid cortisol observed in
subgroups-II, IICE, III and IIICE supported the concept
that the increased synthesis of corticotrophin releasing
hormone resulted in hyperleptinemia. Hypercortisolemia
has been reported to interfere further with leptin’s inter-
action with its receptor resulting in central leptin resist-
ance in them [45,46]. This was manifested in this study by
the fact that the Zn-HL-diet and CE mixed diets fed
groups of rats continued to feed more and gained more
body weight in spite of their higher circulating leptin
levels. Active leptin controls the food intake and fat mass
of the animals but it failed to do so in these rats due to
the onset of leptin resistance. In ME treated rats, there
was a lesser degree of adiposity and lesser leptin produc-
tion and its secretion from adipose tissues in the circulat-
ing blood than those of subgroups-II, IICE, III and IIICE.The changes in leptin levels in different groups of rats
in this study can be attributed to the changes in the min-
eral status of Zn and Cu. Zn levels were higher in liver,
hair and blood serum, and Cu levels were significantly
less in liver and hair but higher in blood serum in sub-
groups-II, IICE and III, IIICE than the control group-I.
The change in leptin level in ME treated rats linked to
the level of Cu in it, which resulted in the reduction of
Zn and rise of Cu in their tissues (hair and liver) in
subgroups-IIME and IIIME than those of subgroups-II
and III as well as subgroups-IICE and IIICE respectively
(Figure 4a, 4b, 4c). The rise in Cu and fall of Zn in tissues
resulted in the fall of leptin close to control group in
subgroups-IIME and IIIME leading to normoleptinemia
both in its synthesis and activity in them. Accordingly, it
resulted in the reduction of food intake and consequently
less absorption of nutrients and resultant reduction in
gain in body weight recorded in subgroups-IIME and
IIIME rats. The dietary Cu supplementation has also
been reported to reduce fat depth [47] by not affecting
the leptin gene expression but through lypolytic activity
of Cu in adipose tissue [48]. The reduction of fat mass
caused by Cu in turn contributed to the reduction in
serum leptin level [49].
Further the levels of Zn, Cu and Mg that have been
found to alter both in serum and tissues of subgroups-II,
IICE, III, IIICE compared to the control indicating that
Zn when in excess even in pharmacological doses in
diet, over a period of time, replaces Cu and Mg in tissues
leading to their leaching into the blood and excretion in
urine resulting in their deficiencies. This is because of
hypercortisolemia which stimulates the synthesis of Cu
containing protein ceruloplasmin and Zn binding pro-
tein metallothionein in liver and other tissues. Once
ceruloplasmin is synthesized, it is transported into the
blood resulting in a reduction of Cu in tissues with con-
comitant increase in serum Cu and stimulated increase
of metallothionein elevates Zn concentration in tissues.
This leads to the imbalance of Cu and Zn concentrations
in the serum and different tissues [17]. The deficiency of
Cu in soft tissues have been shown to decrease Cu-
metalloenzymes notably Zn-Cu superoxide dismutase,
catalase and selinoglutathione peroxidase which form ac-
tive component of antioxidant defense system [50,51].
Their reduction results in proinflammatory action by in-
creasing C-reactive protein which is positively correlated
with interleukin that induces production of C-reactive
protein resulting in hypercotisolemia [52], a contributing
factor in inducing hyperleptinemia as observed in sub-
groups-II, IICE and III, IIICE. Whereas, ME treatment
to subgroups-IIME and IIIME rats, resulted in reversal
of Zn, Cu and Mg levels in soft tissue approaching close
to control group relieving the oxidative stress by restor-
ing antioxidant enzyme activities [50] and alteration in
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free radical formation leading to normocortisolemia.
Thus the reversal of ionic balance, intestinal architec-
ture, serum insulin and cortisol collectively contributed
to normoleptinemia in rats fed ME.
Conclusion
The data suggest that Zn-induced leptin resistance due
to increased oxidative stress can be attenuated through
restoring the ionic balance of Zn, Cu and Mg through
inclusion of antioxidants in diet such as found in these
modified eggs. But further clinical studies are required
before they are put to use for human consumption.
Additional file
Additional file 1: (a-e) Electro-micrographs of intestinal mucosal
epithelial cells (jejunum) showing the microvilli (MV), terminal web
(TW), nucleus (N), mitochondria (M) and endoplasmic reticulum (ER)
in control group-I (a), subgroup-IICE (b), subgroup-IIICE (c),
subgroup-IIME (d) and subgroup-IIIME (e) respectively (subgroup-II
and subgroup-III, not shown because the changes in their
cytoarchitecture were similar to subgroups- IICE and IIICE).
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